Reticuloendotheliosis virus (REV) causes an immunosuppressive, oncogenic, and runting syndrome in many avian hosts worldwide. The immunosuppression caused by REV can decrease the antibody levels of vaccines and subsequent increase susceptibility to secondary infections. There are no commercial vaccines or effective drugs to control REV infections at present. To investigate the REV infection status in chickens in China, 25,224 sera from 573 chicken flocks, collected between 2005 and 2015, were measured for REV antibodies using an enzyme-linked immunosorbent assay. The seroprevalence of REV antibodies in the flocks was 56.20% (322/573) and the overall seroprevalence in individual chickens was 13.91% (3,509/25,224). Of the 23 regions sampled, all provinces, except Heilongjiang, produced positive samples. Guangxi had the highest rate, of 57.84%. The virus-positive rate also tended to increase as the chickens aged. Our study indicates that REV infection has been common in China over the past decade.
INTRODUCTION
The reticuloendotheliosis viruses (REVs) are a group of type C avian retroviruses that includes a variety of strains. These viruses cause an oncogenic, immunosuppressive, and runting syndrome and their natural hosts include chicken, turkey, duck, goose, pheasant, peafowl, and several other bird species (Bohls et al., 2006; Zhai et al., 2016) . The immunosuppression caused by REV infection increases the possibility of concurrent or secondary infections and reduces the birds' immune responses to other vaccines. Co-infection with REV and other immunosuppressive pathogens is associated with increased cases of tumors in chickens in China (Cui et al., 2009; Bao et al., 2015) . REV can be transmitted vertically in eggs, horizontally by contact with infected birds, or mechanically by insect vectors (Witter et al., 1982; Davidson and Braverman, 2005) . REV is widely reported to integrate into large DNA viruses or contaminate other vaccines, which can promote the spread of REVs (Liu et al., 2009; Koo et al., 2013; Mzula et al., 2014; Woźniakowski et al., 2015; Li et al., 2016 
MATERIALS AND METHODS

Birds and Study Area
The survey was conducted during 2005 to 2015 in 23 provinces of China. In total, 573 flocks of different sizes, involving 25,224 serum samples, were collected that were brought in for surveillance of other diseases to the Diagnostic & Research Center of Livestock and Poultry Epidemic Diseases, China Agricultural University.
Sample Collection
Blood samples from 30 to 70 birds per flock were obtained by subalar vein puncture. Blood was collected in 1.5 mL microcentrifuge tubes, allowed to clot at room 3893 temperature for 1 h and then centrifuged at 21,000 × g for 5 min at 4
• C. Sera were transferred to clear tubes and stored at −80
• C until analysis.
Serology
The serum samples were tested for anti-REV antibodies using a commercially available enzyme-linked immunosorbent assay (ELISA) kit (IDEXX, Westbrook, ME) with a catalog number KL406. Briefly, the serum samples were diluted 1:500 in phosphate-buffered saline and analyzed for the presence of IgG antibodies specific for REV, with the ELISA. Sera with sample/positive (S/P) values above the cut-off level of 0.50 were considered positive, according to the manufacturer's instructions.
RESULT AND DISCUSSION
To understand the REV infection status of chickens in 2005 to 2015, 25,224 chickens belonging to 573 different flocks were sampled in 23 province of China. Of the 573 chicken flocks, 322 flocks (56.2%) were positive for REV antibodies. The seroprevalence in individual chickens ranged from 7.49% to 22.83%, with an overall seropositive rate of 13.91%, as shown in Table 1 .
When the data were classified according to the 23 regions sampled, each region had positive samples, except Heilongjiang Province. The seroprevalence in Guangxi and Guangdong were both over 45%, obviously higher than the average value of 12.92% (Figure 1) . Southern China had a higher average positive rate (20.51%) than the north of China (14.0%).
To investigate the relevance of the REV-seropositive rates during the different chicken growth stages, the samples were divided into 8 age classes. At 1 to 3 d old, the antibody-positive rate was 3.27%. After 22 wk, the seroprevalence had gradually increased to almost 20%. These data show that the seropositive rate tended to increase with the age of the chickens (Figure 2) . This serological survey of REV revealed its prevalence in the chickens in 23 provinces of China over a single decade. All 23 provinces tested, except Heilongjiang, and chickens of all ages were positive for REV antibodies. Of the individual chickens investigated in China, 13.91% were infected with REV and the infection rate gradually increased from 7.49% in 2005 to 15.17% in 2015.
Of the 573 chicken flocks tested, 322 (56.2%) were positive. Because no vaccination against REV is available in China, the presence of antibodies against REV in the serum samples indicates field infections. Therefore, the serological results of this study indicate that REV infection was common in China during this period.
The antibody-positive rates of the different provinces ranged from 0% (Heilongjiang) to 57.84% (Guangxi), with an average rate of 12.92%. We may have detected no REV-positive serum samples in Heilongjiang because significantly fewer samples were collected from Heilongjiang than from the other provinces. Studies have shown that REV can be transmitted by insects, especially mosquitoes (Motha et al., 1984; Witter and Salter, 1989; Davidson and Braverman, 2005) . Southern China has more mosquitoes than northern China, which necessarily increases the likelihood of REV transmission. Consequently, the southern provinces displayed a higher average seroprevalence than those in the north.
REV infection is quite common in mature breeder chickens. As our results show, the REV infection rate increased as the age of the chickens increased. Anti-REV antibodies can be transmitted with maternal antibodies, but maternal antibody levels do not increase with age, so it is likely that the high antibody titers in these chickens were a response to field infections. No commercial REV vaccine is currently available, but several researchers believe that REV can be eradicated by a series of procedures, such as breaking the transmission route, eliminating REV-positive chickens, and establishing biological safety measures. The successful eradication of avian leukemia virus with this approach has been reported in many countries (Payne and Venugopal, 2000) . Some researchers have also proposed that vaccination against REV with suitable strategies would prevent many early REV infections and break the vertical transmission cycle of this virus, and have therefore attempted to develop DNA vaccines against REV (Li et al., 2013) .
In this study, we performed the serological survey of REV infections using a commercial ELISA kit (IDEXX). The serum samples from 25,224 birds were collected that were brought in for surveillance of other diseases to the Diagnostic & Research Center of Livestock and Poultry Epidemic Diseases in China Agricultural University. Statistical analysis was not performed in this survey because this was a survey and not a comparison. Our results demonstrate that REV infection was common in China in the last decade. The worldwide distribution of REV and the potential risk it poses necessitate the epidemiological investigation and prediction of REV infection severity in the poultry industry.
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